The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
President-elect Lai to present 4 key themes in inaugural speech
05/18/2024 10:58 PM - Politics
A quick take on why 'legislative reform bills' are hotly debated
05/18/2024 10:40 PM - Politics
Lawmakers visit Taiping Island, urge Lai to reaffirm sovereignty
05/18/2024 09:30 PM - Politics
Amid chaos, bills on president's report to Legislature closer to passage
05/18/2024 08:53 PM - Politics
Lai to assume presidency amid geopolitical and domestic challenges
05/18/2024 05:24 PM